Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C∗06 Status.

BioMed research international - 1 Jan 2022

Queiro Rubén, Coto-Segura Pablo, Braña Ignacio, Pino Marina, Burger Stefanie

Abstract excerpt

The human leukocyte antigen-C∗06 (HLA-C∗06, formerly HLA-Cw6) is the main genetic biomarker in psoriatic disease. It has been related to several phenotypic traits in psoriatic disease, but its role in relation to cardiometabolic comorbidities is unknown at present. Here, we analyze the potential connections between this biomarker and the cardiometabolic profile of these patients. We carried out a cross-sectional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Psoriatic
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Genetic Predisposition to Disease

Share to Heart Disease Risk Factors

Share to HLA-C Antigens

Share to Psoriasis

Share to Spondyloarthritis Studies and Treatments

Source

Open in PubMed Open full text

Identifiers

PMID: 35127937
DOI: 10.1155/2022/1451193
PMCID: PMC8813215

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C∗06 Status.PMID 35127937Read ↗

Searching for a Novel HLA-Cw6-Linked Cardiometabolic Endotype in Psoriatic DiseaseSemantic proximity Read ↗

Influence of the Hla-Cw6 Allele and <em>IFIH1/MDA5</em> Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic DiseaseSemantic proximity Read ↗

Cardiometabolic Candidate Endotypes in Psoriatic Disease: Integration of Clinical, Metabolic, and Immunogenetic Data Across Psoriasis and Psoriatic ArthritisSemantic proximity Read ↗

Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis.Semantic proximity Read ↗

Body Composition, Cardiometabolic Risk Factors and Comorbidities in Psoriasis and the Effect of<i>HLA-C*06:02</i>Status: The HUNT Study, NorwaySemantic proximity Read ↗

HLA-Cw6 in Psoriatic Arthritis: Clinical Phenotype and Therapeutic Impact.Semantic proximity Read ↗

HLA-Cw6 and psoriasis.Semantic proximity Read ↗

HLA-B27 and psoriatic disease: a modern view of an old relationship.Semantic proximity Read ↗

HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population.Semantic proximity Read ↗

Psoriasis: epidemiology.Semantic proximity Read ↗

HLA-C*06 and psoriasis: susceptibility, phenotype, course and response to treatment.Semantic proximity Read ↗

Significance of association of HLA-C and HLA-E with psoriatic arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.